Solana Company (HSDT) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Solana Company  (NASDAQ: HSDT)


Solana's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Solana's ROI in the first quarter of 2026?
Solana Company recorded a cumulative net loss of $-137 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -55.93%.

Within the Healthcare sector 523 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from 3000 to 3613.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Investment Change TTM 7024.8 % 4659.64 % 2208.02 % -46.13 % -48.43 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 198 302 473 6 1
Return On Investment (TTM) -55.93 % -20.91 % -307.53 % -653.06 % -380.38 %
HSDT's Overall Ranking # 3613 # 3000 # 4008 # 3776 # 2447
Seq. Investment Change TTM 25.1 % 62.41 % 3595.09 % -5.1 % -16.43 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -137 -41 -370 -21 -13

HSDT Company Profile >> Back to HSDT Roi Comparisons >> See Annual HSDT Return On Investment



Return On Investment HSDT's Ranking
Within: No.
Industry # 132
Sector # 524
Overall # 3613

Return On Investment Statistics
High Average Low
-20.91 %
-240.49 %
-1754.25 %
(Dec 31 2025)   (Mar 31 2019)



  News about Solana Company Return on Investment ROI

Helius Medical Technologies Announces Inducement Grants Amidst Negative Financial Performance and Share Price Decline,

August 16, 2024


Helius Medical Technologies, Inc. Announces Inducement Grants and Reports Negative Return on Investment
NEWTON, Pa., Aug. 16, 2024 - Helius Medical Technologies, Inc. (Nasdaq: HSDT), a leading neurotech company focused on neurological wellness, announced today that it has approved equity awards under Helius 2021 Inducement Plan as a material inducement to three new hires. The approval was made by the company s independent directors in accordance with Nasdaq Listing Rule 5635(c)(4), which requires a public announcement of equity awards not made under a stockholder-approved equity plan.
The new equity awards, effective August 14, 2024, demonstrate Helius commitment to attracting and retaining top talent. By granting these awards, Helius aims to incentivize the individuals to join the company and contribute to its continued growth and success in the neurotech industry.

Breakthrough Neurorehabilitation Therapy Shows Promise in Stroke Treatment

June 17, 2024


Introduction
Helius Medical Technologies, Inc. has reached a significant milestone in its U.S. Registrational Program in Stroke, announcing the completion of site participation enrollment. This groundbreaking program aims to revolutionize stroke rehabilitation using the innovative Portable Neuromodulation Stimulator (PoNS) Therapy. The inclusion of renowned neurorehabilitation centers REHABOLOGYM, Neurology Center of New England, and MGH Institute of Health Professions highlights the growing recognition and potential of this therapy. Furthermore, a complementary study on the use of PoNS Therapy in Canada is underway, with the goal of supporting reimbursement in Canada and gaining U.S. approval for stroke treatment.
Revolutionizing Stroke Rehabilitation
Stroke, a leading cause of disability worldwide, has prompted researchers and medical professionals to continually explore new avenues for effective rehabilitation. Helius Medical Technologies is leading the charge with their PoNS Therapy, a non-invasive neurorehabilitation device designed to stimulate the brain and facilitate neuroplasticity in stroke survivors.





Financial Statements
Solana's I. Quarter Investments $ 198 Millions HSDT's Balance sheet
Solana's I. Quarter Income $ -100 Millions Quarterly HSDT's Income Statement
HSDT's Income by Division See HSDT's Income by Division


HSDT Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 301 1 6 15 11
Y / Y Investment Growth 21721.1 % -76.28 % -62 % 33.63 % 177.69 %
Net Income in Millions -41 -12 -9 -14 -18
Y / Y Net Income Growth - - - - -
Annual Return On Investment -13.59 % -851.49 % -152.24 % -91.98 % -158.37 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
HSDT's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for HSDT's Competitors
Subscribers only: Roi for Solana's Suppliers
Subscribers only: Return On Investment for HSDT's Customers

Other Ratios
HSDT's Roa HSDT's Inventory Turnover Ratio HSDT's Growth Rates HSDT's Dividend Statistics
HSDT's Profitability Ratios HSDT's Asset Turnover Ratio HSDT's Dividend Growth
HSDT's Roe HSDT's Valuation Ratios HSDT's Financial Strength Ratios HSDT's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI

Date modified: 2026-08-30T14:52:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.